Sechenov University.
Moscow, 119991, Russia
NCT Number: NCT04386564
The authors hypothesize that the SARS-CoV-2 virus can affect the kidneys, causing them to be damaged. The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID-19.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Moscow, 119991, Russia
In December 2019, an outbreak of the 2019 novel coronavirus disease (COVID-19) caused by the SARS coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China. It has spread rapidly to other areas in China and worldwide. The most common manifestations of COVID-19 included fever, dry cough, dyspnea, myalgia, fatigue and radiographic evidence of pneumonia. Complications (acute respiratory distress syndrome, shock, acute cardiac injury, secondary infection, and acute kidney injury) and death may occur in severe cases. Recent reports showed that extrapulmonary symptoms (intestinal symptoms in 10-20% of patients) and renal failure in some patients may be associated with the interaction of the virus with angiotensin-converting enzyme 2 (ACE-2) receptors in other organs. It was suggested that ACE-2 expression in the kidneys can be the cause of kidney injury occurring in a number of patients with SARS-CoV-2.However, ACE-2 is not the only possible cause of kidney injury - sepsis-related cytokine storm can also lead to damage of kidney parenchyma.
The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID-19.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of renal function, expression of viral RNA in urine and assessment of radiological changes will be performed
Other names: chest and abdominal CT scan, CRP, Hb, Presepsin, eGFR, Ccr, UACR, UMA, Proteinuria
Time frame: 2 months
estimated glomerular filtration rate (eGFR), ml/min, in groups with mild, moderate and severe COVID-19
Time frame: 2 months
viral RNA concentration in urine, ME/ml
Time frame: 2 months
albumine excretion with urine, g/ml
Time frame: 2 months
estimated glomerular filtration rate (eGFR), ml/min
Time frame: 2 months
Duration of viral RNA detection in urine by PCR, weeks
Time frame: 2 months
expression of ACE-2 by imminohistochemistry at autopsy specimen
I.M. Sechenov First Moscow State Medical University
Other
Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT05765396
COVID-19, COVID-19 Pneumonia
Fort Sam Houston, Texas, United States
View Trial DetailsNCT07089706
COVID-19, Coronaviridae Infections
Atlanta, Georgia, United States
View Trial DetailsNCT07095231
COVID-19, Coronaviridae Infections
Rochester, New York, United States
View Trial Details